Basis for defective responses of rheumatoid arthritis synovial fluid lymphocytes to anti-CD3 (T3) antibodies.
Martin Lotz(Scripps Research Institute), J H Vaughan(National Health Laboratory Service), Constantine D. Tsoukas(San Diego State University), Charles A. Dinarello(University of Colorado Anschutz Medical Campus), Dennis A. Carson(University of California San Diego), Charles A. Robinson(Center for Global Development)
Cited by 87
Related Papers
Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants
|Nature Medicine|1997|916
Interleukin-1 Receptor Blockade Is Associated With Reduced Mortality in Sepsis Patients With Features of Macrophage Activation Syndrome
|Critical Care Medicine|2015|858
Differential requirement for the activation of the inflammasome for processing and release of IL-1β in monocytes and macrophages
|Blood|2008|777
Sjögren's syndrome. Proposed criteria for classification
|Arthritis & Rheumatism|1986|685
OLT1177, a β-sulfonyl nitrile compound, safe in humans, inhibits the NLRP3 inflammasome and reverses the metabolic cost of inflammation
|Proceedings of the National Academy of Sciences|2018|556